Abstract:Resorbable Mg and Mg alloys have gained significant interest as promising biomedical materials. However, corrosion of these alloys can lead to premature reduction in their mechanical properties, and therefore their corrosion rate needs to be controlled. The aim of this study is to select an appropriate environment where the effects of coatings on the corrosion rate of the underlying Mg alloy can be discerned and measured in a relatively short time period. The corrosion resistance of uncoated AZ31 alloy in different solutions [Hank's Balanced Salt Solution, 1× phosphate buffered solution (PBS), 4× PBS, 0.9%, 3.5%, and 5 M sodium chloride (NaCl)] was determined by measuring the weight loss over a 2 week period. Upon exposure to physiological solutions, the uncoated AZ31 alloys exhibited a variable weight increase of 0.4 ± 0.4%. 3.5% and 5 M NaCl solutions led to 0.27 and 9.7 mm/year corrosion rates, respectively, where the compositions of corrosion products from AZ31 in all saline solutions were similar. However, the corrosion of the AZ31 alloy when coated by electrochemical oxidation with two phosphate coatings, one containing fluorine (PF) and another containing both fluorine and silica (PFS), showed 0.3 and 0.25 mm/year corrosion rates, respectively. This is more than 30 times lower than that of the uncoated alloy (7.8 mm/year), making them promising candidates for corrosion protection in severe corrosive environments. Cross-sections of the samples showed that the coatings protected the alloy from corrosion by preventing access of saline to the alloy surface, and this was further reinforced by corrosion products from both the alloy and the coatings forming an additional barrier. The information in this paper provides a methodology for evaluating the effects of coatings on the rate of corrosion of magnesium alloys.

Influence of Artificial Biological Fluid Composition on the Biocorrosion of Potential Orthopedic Mg-Ca, Az31, Az91 Alloys

Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg–Ca, AZ31, AZ91 alloys

Biodegradation of Az31 and We43 Magnesium Alloys in Simulated Body Fluid

Evaluation of the Corrosion Behavior of AZ31 Magnesium Alloy with Different Protein Concentrations

Evaluation of Corrosion Performance of AZ31 Mg Alloy in Physiological and Highly Corrosive Solutions

Corrosion Behavior of AZ91D Magnesium Alloy in Three Different Physiological Environments

Electrochemical Behavior Al[sub 2]o[sub 3]∕al Coated Surgical AZ91 Magnesium Alloy in Simulated Body Fluids

Corrosion behavior of biomedical AZ91 magnesium alloy in simulated body fluids

Biocorrosion behavior of magnesium alloy in different simulated fluids for biomedical application

Corrosion Behavior of Mg-Ca-Zn Alloys in Simulated Body Fluid

Alloying and Brushite Coating Improve Corrosion Resistance of Magnesium in a Simulated Physiological Environment

Corrosion Products on Biomedical Magnesium Alloy Soaked in Simulated Body Fluids

Long-term Corrosion Inhibition Mechanism of Microarc Oxidation Coated AZ31 Mg Alloys for Biomedical Applications

Influence of MC3T3-E1 preosteoblast culture on the corrosion of a T6-treated AZ91 alloy

Effects of Inorganic Ions, Organic Particles, Blood Cells, and Cyclic Loading on in Vitro Corrosion of Mg Al Alloys

Effects of Flow Velocity and Different Corrosion Media on the in Vitro Bio-Corrosion Behaviors of AZ31 Magnesium Alloy

Effect of Chemical Treatment on the Corrosion Behavior of Mg-2Zn-1Mn (ZM21) Magnesium Alloy

Electrochemical Behavior of Biocompatible AZ31 Magnesium Alloy in Simulated Body Fluid

Corrosion Degradation of AXJ530 Magnesium Alloy in Simulated Pysiological Fluid and Its Mitigation by Fluoride and Chitosan Coatings for Osteosynthetic Applications

Corrosion Electrochemical Behavior of AZ31 and AZ61 Magnesium Alloys in Simulated Sea Water

Corrosion behavior and microstructure of biomedical Mg-Zn-Mn-Gd alloys